FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089740219> ?p ?o ?g. }

• W3089740219 endingPage "78" @default.
• W3089740219 startingPage "70" @default.
• W3089740219 abstract "The goal of the work. Assess the relationship between eNOS gene genotypes (T786C) and some clinical and laboratory parameters in patients with alcoholic liver disease (ALD) in combination with arterial hypertension (AH).Material and methods. 97 patients diagnosed with AHP were examined: 62 patients with ALD with AH (group A) and 35 patients with ALD (group B). Serum content of C-reactive protein, tumor necrosis factor-α (TNFα), transforming growth factor-β1 (TGFβ1), interleukin-10 (IL-10), 8-isoprostane, D-dimer was determined by enzyme-linked immunosorbent assay. The functional state of the endothelium was assessed by the content in the blood of stable metabolites of nitrogen monoxide (nitrites / nitrates), endothelin-1 (ET-1), intercellular adhesion molecules-1 (ICAM-1). Total blood coagulation potential (plasma recalcification time), prothrombin time (PT), thrombin time (TT), activated partial thromboplastin time (APTT), plasma fibrinogen levels, antithrombin III (ATIII) activity, factor XIII (F XIII) activity was determined by traditional methods. Spontaneous platelet aggregation was also studied. To determine the eNOS mutation (T786C), rs2070744 used a protocol with oligonucleotide primers using the method of allele-specific PCR.Results. When studying the frequency of genotypes by the polymorphic variant of the eNOS gene (T786C), it was found that the frequency of TT genotype among patients with ALD with hypertension was 46.8%, CT - 57.1% and SS - 17.2%. Among patients with ALD, the following distribution of genotypes was found: TT - 25.7%, ST - 57.1% and SS - 17.2%. We found a significant difference between the group of patients with ALD with AH and the isolated group of ALD by TT genotype. It was found that the level of ET-1 and the intercellular adhesion molecule (ICAM-1) were significantly higher in patients with ALD with AH by TT genotype compared with the isolated course of ALD. However, the level of total nitric oxide in the combined course of ALD with hypertension was lower than in patients with ALD without hypertension in the presence of this genotype. At the same time, in the combined course of ALD and hypertension, the level of systemic inflammation and oxidative stress is associated with the TT genotype by a polymorphic variant of the eNOS gene (T786C). When studying the state of hemostasis in the combined course of ALD and hypertension, it was found that APTT for the TT genotype was 17.7% higher than in group B. This indicator also had a difference in the middle group between the TT and CT genotypes (by 13.1%) and TT and CC (by 28.3%). The level of D-dimer between groups A and B also had a significant difference in the TT genotype (higher by 14.7% for the combination of ALD and AH). Spontaneous platelet aggregation was significantly higher by 7.7% in patients with ALD with hypertension by TT genotype. In the latter group of patients, factor XIII was significantly lower by 12.6% compared with the group of patients with ALD. Indicators such as plasma recalcification time, prothrombin index and time, thrombin time did not differ significantly between groups of patients.Conclusion. The development of hypertension in patients with ALD is associated with the presence of a homozygous TT genotype for a polymorphic variant of the eNOS gene (T786C). It was found that in patients with ALD with hypertension by TT genotype higher levels of ET-1 and intercellular adhesion molecules ICAM-1 are observed at a lower level of total nitric oxide compared with patients with ALD. The most probable differences in systemic inflammation (IL-10, CRP, TGFβ1) and oxidative stress marker (8-isoprostane) are characteristic of the TT genotype for the polymorphic variant of the eNOS gene (T786C) in patients with ACP with hypertension compared with the isolated course of ALD. Hemostasis parameters such as APTT, antithrombin III, D-dimer, spontaneous platelet aggregation and factor XIII were associated with the TT genotype in patients with ALD with hypertension by the polymorphic variant of the eNOS gene (T786C)." @default.
• W3089740219 created "2020-10-08" @default.
• W3089740219 creator A5079832724 @default.
• W3089740219 date "2020-06-04" @default.
• W3089740219 modified "2023-09-26" @default.
• W3089740219 title "Features of clinical and laboratory indicators in alcoholic liver disease in combination with arterial hypertension depending on T786C polymorphism of the eNOS gene" @default.
• W3089740219 cites W1963488514 @default.
• W3089740219 cites W2108346443 @default.
• W3089740219 cites W2318527216 @default.
• W3089740219 cites W2375810900 @default.
• W3089740219 cites W2499166290 @default.
• W3089740219 cites W2560436595 @default.
• W3089740219 cites W2596752773 @default.
• W3089740219 cites W2769003329 @default.
• W3089740219 cites W2993450692 @default.
• W3089740219 cites W953089013 @default.
• W3089740219 doi "https://doi.org/10.24061/2413-0737.xxiv.2.94.2020.46" @default.
• W3089740219 hasPublicationYear "2020" @default.
• W3089740219 type Work @default.
• W3089740219 sameAs 3089740219 @default.
• W3089740219 citedByCount "0" @default.
• W3089740219 crossrefType "journal-article" @default.
• W3089740219 hasAuthorship W3089740219A5079832724 @default.
• W3089740219 hasBestOaLocation W30897402191 @default.
• W3089740219 hasConcept C104317684 @default.
• W3089740219 hasConcept C126322002 @default.
• W3089740219 hasConcept C134018914 @default.
• W3089740219 hasConcept C135763542 @default.
• W3089740219 hasConcept C185592680 @default.
• W3089740219 hasConcept C203014093 @default.
• W3089740219 hasConcept C2777622882 @default.
• W3089740219 hasConcept C2778261982 @default.
• W3089740219 hasConcept C2778326061 @default.
• W3089740219 hasConcept C2779036427 @default.
• W3089740219 hasConcept C2780434524 @default.
• W3089740219 hasConcept C519581460 @default.
• W3089740219 hasConcept C55493867 @default.
• W3089740219 hasConcept C71924100 @default.
• W3089740219 hasConcept C76252995 @default.
• W3089740219 hasConcept C89560881 @default.
• W3089740219 hasConceptScore W3089740219C104317684 @default.
• W3089740219 hasConceptScore W3089740219C126322002 @default.
• W3089740219 hasConceptScore W3089740219C134018914 @default.
• W3089740219 hasConceptScore W3089740219C135763542 @default.
• W3089740219 hasConceptScore W3089740219C185592680 @default.
• W3089740219 hasConceptScore W3089740219C203014093 @default.
• W3089740219 hasConceptScore W3089740219C2777622882 @default.
• W3089740219 hasConceptScore W3089740219C2778261982 @default.
• W3089740219 hasConceptScore W3089740219C2778326061 @default.
• W3089740219 hasConceptScore W3089740219C2779036427 @default.
• W3089740219 hasConceptScore W3089740219C2780434524 @default.
• W3089740219 hasConceptScore W3089740219C519581460 @default.
• W3089740219 hasConceptScore W3089740219C55493867 @default.
• W3089740219 hasConceptScore W3089740219C71924100 @default.
• W3089740219 hasConceptScore W3089740219C76252995 @default.
• W3089740219 hasConceptScore W3089740219C89560881 @default.
• W3089740219 hasIssue "2 (94)" @default.
• W3089740219 hasLocation W30897402191 @default.
• W3089740219 hasOpenAccess W3089740219 @default.
• W3089740219 hasPrimaryLocation W30897402191 @default.
• W3089740219 hasRelatedWork W1979224362 @default.
• W3089740219 hasRelatedWork W2054450016 @default.
• W3089740219 hasRelatedWork W2059415529 @default.
• W3089740219 hasRelatedWork W2140777419 @default.
• W3089740219 hasRelatedWork W2148878791 @default.
• W3089740219 hasRelatedWork W2349684057 @default.
• W3089740219 hasRelatedWork W2364718100 @default.
• W3089740219 hasRelatedWork W2372619240 @default.
• W3089740219 hasRelatedWork W2396246764 @default.
• W3089740219 hasRelatedWork W2398874141 @default.
• W3089740219 hasVolume "24" @default.
• W3089740219 isParatext "false" @default.
• W3089740219 isRetracted "false" @default.
• W3089740219 magId "3089740219" @default.
• W3089740219 workType "article" @default.